Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
about
Suberoylanilide hydroxamic acid reactivates HIV from latently infected cellsDrug-class specific impact of antivirals on the reproductive capacity of HIVCompartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementiaHIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirsMulti-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapyPharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infectionModelling HIV and MTB co-infection including combined treatment strategiesExplaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug actionTargeted cytotoxic therapy kills persisting HIV infected cells during ARTEstimating HIV-1 fitness characteristics from cross-sectional genotype dataOptimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor SettingsA comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection.Raltegravir: The evidence of its therapeutic value in HIV-1 infection.A model of HIV-1 infection with two time delays: mathematical analysis and comparison with patient data.APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study.A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN TrialRaltegravir in combination with other antiretroviral agents for the treatment of HIV infection.The role of unintegrated DNA in HIV infectionTiming of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals.The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations.Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).Antiretroviral dynamics determines HIV evolution and predicts therapy outcome.Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivoDose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugsModeling HIV persistence, the latent reservoir, and viral blips.A novel method for determining the inhibitory potential of anti-HIV drugs.New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo.Raltegravir in the management of HIV-infected patients.Raltegravir in treatment naive patients.Novel integrase inhibitors for HIV.Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients.Mechanistic Models Predict Efficacy of CCR5-Deficient Stem Cell Transplants in HIV Patient Populations.Kinetics of the viral cycle influence pharmacodynamics of antiretroviral therapy.Nuclear landscape of HIV-1 infection and integration.Model with two types of CTL regulation and experiments on CTL dynamics.Stage-dependent inhibition of HIV-1 replication by antiretroviral drugs in cell culture.Dynamics of an HIV Model with Multiple Infection Stages and Treatment with Different Drug Classes.A complete categorization of multiscale models of infectious disease systems.
P2860
Q24644201-09B2DB35-3DFA-46C5-82D9-2CA565691B91Q28473451-9D02B1E1-77A2-4A8B-930C-6C4470BE3065Q28475360-B0A876C6-ADAB-47D6-914E-1DCF93B0090BQ28477500-D67D6C63-F2F4-46FD-8C7C-B7318ED68F08Q28480578-37B4A83D-5E81-48CF-8051-144DF9DF492EQ28481276-247D5C71-9444-4594-8FAF-DFCD0AF573D5Q28485357-F0224718-6AA9-4F51-B96B-1334AF5339BBQ28489076-8DF0EEB2-0E9C-44B1-865B-AC030928B004Q28538598-3EA26507-60E6-4B48-B159-06B1B79D5C6DQ28544753-00B0B567-C050-4DD8-9719-16CCC55F58CEQ28547109-7F630EC6-0A99-4002-92EB-702081C97963Q30596957-3DEBF23B-5F94-4403-A447-07EF140B6A18Q33973930-4D53565C-DF0A-4161-AE6B-5AD1EAEACA33Q34080406-C78B6659-733D-419A-B97B-9EBD31423242Q34749384-7948346C-5756-4973-ABD1-AEDEF66B6A78Q35012981-C4742122-FF09-4E03-AC40-CEDFCD24C128Q35026604-AFAC9305-C600-42D3-8F17-8E355BB75519Q35143730-78A0CA1C-ED20-4E03-968F-33F3B1FAA911Q35274822-26F794D0-E4B7-48DA-BE13-C13EF26112ECQ35377813-A46A5C93-1BF2-4C5C-8A4E-08C6EA6415A2Q35598505-13A6FAF9-DCB3-4792-8D11-70F87475E122Q36284619-01E06150-72F6-46F7-AAFA-465118B187BAQ36374300-BC75220F-CD7D-497C-AC33-0C7B6DBF7121Q37109548-F5D7662D-67AE-46E1-9C96-0D008474EE98Q37256641-FE9C1C43-1CB3-47E6-8E6C-069362CC2FF3Q37345610-5C92EFE4-B205-4FA3-B144-7AD3507A657CQ37365718-6A7EF2FD-C18E-4B72-BFD1-7CD2F00F9DB2Q37616810-DB64E931-C3E1-4659-B29C-9B5399149600Q37617931-9A7440FD-BFB6-46ED-814C-FE0D22A876B3Q37634326-ACF14480-F267-4B1C-BB6B-B5BBF2F4CB7AQ37644120-28A9C649-3757-4EE7-9436-67C189856B31Q37779774-30A2BD2A-5FBE-46E9-9C95-D401BAC6CC36Q38391209-7E814942-4805-4580-A85B-4683D747A26FQ38574401-ED74D20B-EA18-40B4-BEB8-3EC9EA67D950Q38848973-0268F4E4-C753-4F4F-B121-11E41A070552Q39035944-296ECDDD-AFA6-4751-96D3-48A618C6AB43Q39240571-1421584B-6887-42C2-84C3-8567492A4776Q39758249-29CB912B-8B82-46AA-91AC-A13E044CF8F0Q40026816-88E6941D-C259-4A2C-9852-C7C29FB69FB3Q40076329-0F29774F-CC89-45DA-BFB5-19B04168454F
P2860
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
@ast
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
@en
type
label
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
@ast
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
@en
prefLabel
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
@ast
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
@en
P2093
P2860
P356
P1476
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
@en
P2093
Ahmad R Sedaghat
Jason B Dinoso
P2860
P304
P356
10.1073/PNAS.0711372105
P407
P577
2008-03-24T00:00:00Z